• <progress id="ete9x"></progress>
  • <dd id="ete9x"></dd>

    <dd id="ete9x"><track id="ete9x"></track></dd><tbody id="ete9x"><noscript id="ete9x"></noscript></tbody>

    Vayuan Pharmaceutical currently has more than 30 full-time imported drug registration elites on duty. Vayuan Pharmaceutical selects products suitable for introduction into China based on factors such as patents, pharmacology, toxicology, side effects, therapeutic advantages, product characteristics, intermediate structure, domestic environmental protection, and capacity conversion of domestic pharmaceutical manufacturers.

    Interpretation of marketing authorization
    The drug marketing authorization of Chinese local companies includes drug registration approval documents, national drug registration standards, and drug registration certificates.
    For imported drugs, marketing authorization includes drug registration approval documents, imported drug registration standards, and imported drug license (Imported Drug License-IDL). These documents are issued at the same time as IDL is issued. The industry usually refers to marketing authorization documents collectively as IDL. IDL is issued by NMPA, and the process from application to IDL is called import drug registration or IDL application.